DNA X Inc. authorizes Series B preferred stock issuance
DNA X Inc. amended its charter to authorize up to 1.35 million shares of Series B convertible preferred stock. This issuance authorizes the company to raise capital, potentially pr…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
DNA X Inc. amended its charter to authorize up to 1.35 million shares of Series B convertible preferred stock. This issuance authorizes the company to raise capital, potentially pr…
Eos Energy Enterprises filed a rights certificate detailing a plan to issue common stock and warrants. The filing establishes specific subscription prices and deadlines for existin…
Agassi Sports Entertainment Corp. amended its Registration Rights Agreement to delay the filing deadline for the Initial Registration Statement until July 31, 2026. This administra…
The Board adopted a certificate designating Series D Participating Preferred Stock to support a pre-existing rights offering. This authorizes up to 300,000 new shares and increases…
CNS Pharmaceuticals secured a $22.5 million financing round to support a strategic pivot toward high-value oncology and neurology development. This capital injection validates the …
Mintz Stone issued a legal opinion confirming the validity of Elicio's sale of 4.38 million shares under a July purchase agreement, satisfying regulatory closing conditions.
Idaho Copper Corp confirmed an agreement to sell 3.712 million shares and warrants to ThinkEquity LLC. This move positions the company for a potential public offering or capital ra…
Ares Acquisition Corp III agreed to sell 34.5 million units to underwriters. This filing indicates the company is preparing to complete its initial public offering.
EquipmentShare.com Inc entered into an indenture for $1.35 billion of 7.125% senior secured second lien notes due 2034 with Citibank N.A. as trustee.
Neurogene Inc. entered an underwriting agreement to sell 3.5 million shares and pre-funded warrants. The offering is intended to raise capital for general corporate purposes.
Cadrenal Therapeutics filed a registration statement for a pre-funded common stock purchase warrant. The filing establishes the terms for future equity exercises under a private tr…
Jackson Financial Inc. has entered into a revolving credit agreement valued at $1.25 billion with major financial institutions. The facility, dated June 30, 2026, provides the comp…
OneMedNet Corp agreed to a Standby Equity Purchase Agreement on July 1, 2026, granting the right to sell up to $25 million in common stock to Ya II PN, Ltd. The agreement provides …
Eos Energy Enterprises executed a warrant agreement to issue 6,004,378 shares to Hudson Bay Master Fund at $5.4810 per share. This transaction formalizes an equity financing effort…
Subsidiaries XeCare and Apostrophe finalized a new credit facility with JPMorgan Chase. This financing deal aims to bolster cash flow and working capital.
The company entered an underwriting agreement to sell $350 million of 6.100% notes due 2031 to a syndicate of investment banks. This debt issuance provides the fund with additional…
NASDAQ, Inc. entered into an Amended and Restated Credit Agreement dated June 30, 2026, establishing Revolving A and B facilities with major financial institutions.
Redwire Corp filed an amendment to its credit agreement to increase revolving credit commitments. This modification strengthens the company’s financial flexibility and liquidity.
ClearOne Inc entered into a loan agreement with First Finance Ltd., effective as of June 30, 2026, allowing for up to $1 million in funding at an 11% interest rate. This future-dat…
Digital Realty Trust signed an underwriting agreement with Morgan Stanley to sell 12.3 million shares of common stock. This transaction involves converting non-voting common stock …